BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 21432762)

  • 1. Pneumococcal conjugate vaccines: epidemiology guides clinical use.
    Heininger U
    Klin Padiatr; 2011 Mar; 223(2):59-60. PubMed ID: 21432762
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential benefits from currently available three pneumococcal vaccines for children--population-based evaluation.
    Rückinger S; van der Linden M; Siedler A; von Kries R
    Klin Padiatr; 2011 Mar; 223(2):61-4. PubMed ID: 21271500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriateness of a pneumococcal conjugate vaccine in Brazil: potential impact of age and clinical diagnosis, with emphasis on meningitis.
    Brandileone MC; de Andrade AL; Di Fabio JL; Guerra ML; Austrian R
    J Infect Dis; 2003 Apr; 187(8):1206-12. PubMed ID: 12695999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diversity of pneumococcal conjugate vaccine impact observed through their implementation.
    Dagan R
    Hum Vaccin Immunother; 2016; 12(2):266-7. PubMed ID: 26905677
    [No Abstract]   [Full Text] [Related]  

  • 5. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
    Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL
    Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines.
    von Kries R; Siedler A; Schmitt HJ; Reinert RR
    Clin Infect Dis; 2000 Aug; 31(2):482-7. PubMed ID: 10987709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medical indications and effectiveness of the pneumococcal conjugate vaccine].
    Reinert RR
    Laryngorhinootologie; 2006 Apr; 85(4):291-8; quiz 299-300. PubMed ID: 16615030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pneumococcal vaccination for children and adults].
    Albrich W
    Ther Umsch; 2016; 73(5):235-40. PubMed ID: 27268445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paediatric pneumococcal disease in Central Europe.
    Prymula R; Chlibek R; Ivaskeviciene I; Mangarov A; Mészner Z; Perenovska P; Richter D; Salman N; Simurka P; Tamm E; Tešović G; Urbancikova I; Usonis V
    Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1311-20. PubMed ID: 21667219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood invasive pneumococcal disease in Germany between 1997 and 2003: variability in incidence and serotype distribution in absence of general pneumococcal conjugate vaccination.
    Rückinger S; von Kries R; Reinert RR; van der Linden M; Siedler A
    Vaccine; 2008 Jul; 26(32):3984-6. PubMed ID: 18495301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.
    Albrich WC; Baughman W; Schmotzer B; Farley MM
    Clin Infect Dis; 2007 Jun; 44(12):1569-76. PubMed ID: 17516400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decline in pneumococcal meningitis in Spain after introduction of the heptavalent pneumococcal conjugate vaccine.
    Casado-Flores J; Rodrigo C; Arístegui J; Martínón JM; Fenoll A; Mendez C
    Pediatr Infect Dis J; 2008 Nov; 27(11):1020-2. PubMed ID: 18845983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal conjugate vaccines--a European perspective.
    Reinert RR
    Int J Med Microbiol; 2004 Oct; 294(5):277-94. PubMed ID: 15532987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumococcal diagnosis and serotypes in childhood community-acquired pneumonia.
    Elemraid MA; Sails AD; Thomas MF; Rushton SP; Perry JD; Eltringham GJ; Spencer DA; Eastham KM; Hampton F; Gennery AR; Clark JE;
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):129-32. PubMed ID: 23537785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of pneumococcal conjugate vaccines introduction on antibiotic resistance of
    Ben-Shimol S; Givon-Lavi N; Greenberg D; Stein M; Megged O; Bar-Yochai A; Negari S; Dagan R;
    Euro Surveill; 2018 Nov; 23(47):. PubMed ID: 30482264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of pneumococcal vaccination in infants and young children].
    Adam D; Scholz H
    Klin Padiatr; 2001; 213(3):109-13. PubMed ID: 11417363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales.
    Ladhani SN; Slack MP; Andrews NJ; Waight PA; Borrow R; Miller E
    Emerg Infect Dis; 2013 Jan; 19(1):61-8. PubMed ID: 23259937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing focus on local epidemiology demonstrates potential value of pneumococcal conjugate vaccines in Middle East and North Africa Region.
    Pelton SI
    Vaccine; 2012 Dec; 30 Suppl 6():G1. PubMed ID: 23228351
    [No Abstract]   [Full Text] [Related]  

  • 19. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine.
    Li ST; Tancredi DJ
    Pediatrics; 2010 Jan; 125(1):26-33. PubMed ID: 19948570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal Meningitis Vaccine Breakthroughs and Failures After Routine 7-Valent and 13-Valent Pneumococcal Conjugate Vaccination in Children in France.
    Godot C; Levy C; Varon E; Picard C; Madhi F; Cohen R
    Pediatr Infect Dis J; 2015 Oct; 34(10):e260-3. PubMed ID: 26181894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.